Gandeeva Therapeutics

About:

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Website: https://www.gandeeva.com/

Twitter/X: Gandeeva_Tx

Top Investors: Obvious Ventures, Leaps by Bayer, Lux Capital, Air Street Capital, Amplitude Venture Capital

Description:

Gandeeva Therapeutics is a precision biotechnology company integrating the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop differentiated therapeutics by targeting and modulating key protein-protein interactions. Gandeeva’s structure-guided drug discovery platform encompasses target prediction and validation (SPOTLIGHT™), hit identification by screening virtual and fragment libraries (HYPERFOCUS™), and lead optimization (CRYO-CADD™). Gandeeva has a robust preclinical oncology pipeline targeting difficult-to-treat cancers with novel protein interaction modulators such as interfacial glues (iGlues™) and allosteric inhibitors. Gandeeva is headquartered in the Greater Vancouver area, Canada. Please visit www.gandeeva.com or follow us on LinkedIn and Twitter for more information.